Brief: Mesoblast Ltd Says FY Loss Attributable $81.9 Mln
31/08/2023 02:33
Aug 31 (Reuters) - Mesoblast Ltd MSB.AX :
* FY LOSS ATTRIBUTABLE $81.9 MILLION VERSUS LOSS $91.3 MN
Source text for Eikon: ID:nASX1lS1FF
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M